Pilot Study Efficacy and Tolerance Fish Oil Emulsion Daunorubicin and Cytarabine Treatment of AML Younger Patients

NCT01999413 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)

Interventions

DRUG: OMEGAVEN
DRUG: Daunorubicin
DRUG: Cytarabine

Sponsor

French Innovative Leukemia Organisation

Collaborators

[object Object]